Back
Results - Announcements
Genpharmasec Ltd consolidated sales down 10.32% on year in Q2FY2026, net profit tumbled by 112.59%
11-Aug-2026, 06:50
Genpharmasec Ltd share price slipped 0.94% to Rs 1.05 after the company's net profit plunged by 112.59% to Rs 0.17 crore, while revenue from operations reduced 10.32% to Rs 49.71 crore in Q2FY26 over Q1FY26. The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49465.98 crore, easing 9.74%. It has inched up 1.03% over last one week and jumped by 26.61% in last one month while the market capitalization of Genpharmasec Ltd has remained flat Profit before tax (PBT) of Genpharmasec Ltd stood at Rs 0.26 crore in Q2 FY26, tumbling by 79.20% year-on-year, and tanking 85.95% quarter-on-quarter. EBITDA came in at Rs 1 crore, expanding by 132.00% YoY and crashing by 40.82% sequentially. Total expenses marginally dropped 8.65% to Rs 49.43 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.06 crore, jumping 783.33% YoY, while employee benefits expense was at Rs 1.11 crore, inching up 3.74% YoY. For the TTM ended FY26, revenue from operations advanced 10.88% to Rs 33.72 crore, while net profit tanked by 1017.65% to Rs 1.56 crore, compared to previous TTM. EBITDA saw a sharp decline of 85% to Rs 2.67 crore, and PBT jumped 784% to Rs 2.21 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 3.0 crore in FY26, as against Rs 2.95 crore in FY25. Genpharmasec Ltd nosedived by 47.50% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
Genpharmasec Ltd share price slipped 0.94% to Rs 1.05 after the company's net profit plunged by 112.59% to Rs 0.17 crore, while revenue from operations reduced 10.32% to Rs 49.71 crore in Q2FY26 over Q1FY26. The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49465.98 crore, easing 9.74%. It has inched up 1.03% over last one week and jumped by 26.61% in last one month while the market capitalization of Genpharmasec Ltd has remained flat Profit before tax (PBT) of Genpharmasec Ltd stood at Rs 0.26 crore in Q2 FY26, tumbling by 79.20% year-on-year, and tanking 85.95% quarter-on-quarter. EBITDA came in at Rs 1 crore, expanding by 132.00% YoY and crashing by 40.82% sequentially. Total expenses marginally dropped 8.65% to Rs 49.43 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.06 crore, jumping 783.33% YoY, while employee benefits expense was at Rs 1.11 crore, inching up 3.74% YoY. For the TTM ended FY26, revenue from operations advanced 10.88% to Rs 33.72 crore, while net profit tanked by 1017.65% to Rs 1.56 crore, compared to previous TTM. EBITDA saw a sharp decline of 85% to Rs 2.67 crore, and PBT jumped 784% to Rs 2.21 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 3.0 crore in FY26, as against Rs 2.95 crore in FY25. Genpharmasec Ltd nosedived by 47.50% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.